Growth Metrics

Kraig Biocraft Laboratories (KBLB) Long-Term Debt Issuances (2018 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Long-Term Debt Issuances for 7 consecutive years, with -$230000.0 as the latest value for Q4 2022.

  • Quarterly Long-Term Debt Issuances rose 65.67% to -$230000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Dec 2022, down 8.0% year-over-year, with the annual reading at $2.8 million for FY2022, 8.0% down from the prior year.
  • Long-Term Debt Issuances hit -$230000.0 in Q4 2022 for Kraig Biocraft Laboratories, down from $1.5 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $3.2 million in Q2 2021 to a low of -$670000.0 in Q4 2021.
  • Historically, Long-Term Debt Issuances has averaged $661333.3 across 4 years, with a median of $120000.0 in 2019.
  • Biggest YoY gain for Long-Term Debt Issuances was 231.11% in 2022; the steepest drop was 53.42% in 2022.
  • Year by year, Long-Term Debt Issuances stood at $57000.0 in 2018, then soared by 110.53% to $120000.0 in 2019, then tumbled by 658.33% to -$670000.0 in 2021, then soared by 65.67% to -$230000.0 in 2022.
  • Business Quant data shows Long-Term Debt Issuances for KBLB at -$230000.0 in Q4 2022, $1.5 million in Q2 2022, and $1.5 million in Q1 2022.